Transcatheter Implantation of the MONARC Coronary Sinus Device for Mitral Regurgitation 1-Year Results From the EVOLUTION Phase I Study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for The Treatment of Mitral Regurgitation).

Research output: Contribution to journalArticle

Bibtex

@article{b8a2760a8e1d4ad2b4b160207fb5d9ed,
title = "Transcatheter Implantation of the MONARC Coronary Sinus Device for Mitral Regurgitation 1-Year Results From the EVOLUTION Phase I Study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for The Treatment of Mitral Regurgitation).",
abstract = "This study sought to assess the safety and efficacy of transcatheter valve annuloplasty in patients with mitral regurgitation (MR).",
author = "Jan Harnek and Webb, {John G} and Karl-Heinz Kuck and Carsten Tschope and Alec Vahanian and Buller, {Christopher E} and James, {Stefan K} and Tiefenbacher, {Christiane P} and Stone, {Gregg W}",
year = "2011",
doi = "10.1016/j.jcin.2010.08.027",
language = "English",
volume = "4",
pages = "115--122",
journal = "JACC: Cardiovascular Interventions",
issn = "1876-7605",
publisher = "Elsevier",
number = "1",

}